<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-id journal-id-type="iso-abbrev">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4471093</article-id><article-id pub-id-type="publisher-id">cc14153</article-id><article-id pub-id-type="doi">10.1186/cc14153</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Comparison of three cutaneous antiseptic solutions for the prevention of catheter colonization in an ICU for adult patients: a multicenter prospective randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Yasuda</surname><given-names>H</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Sanui</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Komuro</surname><given-names>T</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Hatakeyama</surname><given-names>J</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Matsukubo</surname><given-names>S</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Kawano</surname><given-names>S</given-names></name><xref ref-type="aff" rid="I5">5</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Yamamoto</surname><given-names>H</given-names></name><xref ref-type="aff" rid="I6">6</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Andoh</surname><given-names>K</given-names></name><xref ref-type="aff" rid="I7">7</xref></contrib><contrib contrib-type="author" id="A9"><name><surname>Seo</surname><given-names>R</given-names></name><xref ref-type="aff" rid="I8">8</xref></contrib><contrib contrib-type="author" id="A10"><name><surname>Shime</surname><given-names>N</given-names></name><xref ref-type="aff" rid="I9">9</xref></contrib><contrib contrib-type="author" id="A11"><name><surname>Noda</surname><given-names>E</given-names></name><xref ref-type="aff" rid="I10">10</xref></contrib><contrib contrib-type="author" id="A12"><name><surname>Saito</surname><given-names>N</given-names></name><xref ref-type="aff" rid="I11">11</xref></contrib></contrib-group><aff id="I1"><label>1</label>Japanese Red Cross Musashino Hospital, Tokyo, Japan</aff><aff id="I2"><label>2</label>Saitama Medical Center Jichi Medical University, Saitama, Japan</aff><aff id="I3"><label>3</label>YokohamaCity Minato Red Cross Hospital, Kanagawa, Japan</aff><aff id="I4"><label>4</label>Kurashiki Central Hospital, Okayama, Japan</aff><aff id="I5"><label>5</label>The Jikei University School of Medicine, Tokyo, Japan</aff><aff id="I6"><label>6</label>Toyonaka Municipal Hospital, Osaka, Japan</aff><aff id="I7"><label>7</label>Sendai City Hospital, Miyagi, Japan</aff><aff id="I8"><label>8</label>Kobe City Medical Center General Hospital, Hyogo, Japan</aff><aff id="I9"><label>9</label>National Hospital Organization Kyoto Medical Center, Kyoto, Japan</aff><aff id="I10"><label>10</label>Kyushu University Hospital, Fukuoka, Japan</aff><aff id="I11"><label>11</label>Nippon Medical School Chiba Hokusoh Hospital, Tiba, Japan</aff><pub-date pub-type="ppub"><year>2015</year></pub-date><pub-date pub-type="epub"><day>16</day><month>3</month><year>2015</year></pub-date><volume>19</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">35th International Symposium on Intensive Care and Emergency Medicine</named-content><named-content content-type="supplement-sponsor">Pubication charges for this supplement were funded by ISICEM.</named-content></supplement><fpage>P73</fpage><lpage>P73</lpage><permissions><copyright-statement>Copyright &#x000a9; 2015 Yasuda et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Yasuda et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://ccforum.com/content/19/S1/P73"/><conference><conf-date>17-20 March 2015</conf-date><conf-name>35th International Symposium on Intensive Care and Emergency Medicine</conf-name><conf-loc>Brussels, Belgium</conf-loc></conference></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The current CDC guideline for the prevention of intravascular catheter-related infections recommends skin preparation with a greater than 0.5% chlorhexidine with alcohol solution before central venous catheter (CVC) or peripheral arterial catheter (AC) placement. However, few studies investigated the superiority of 1% alcoholic chlorhexidine gluconate (1% CHG) over either 0.5% alcoholic chlorhexidine gluconate (0.5% CHG) or 10% aqueous povidone iodine (10% PVI) for the prevention of catheter colonization. The aim of this study is to compare the effectiveness of three skin antiseptic solutions for the prevention of intravascular catheter colonization.</p></sec><sec sec-type="methods"><title>Methods</title><p>This multicenter prospective randomized controlled trial was conducted in 15 Japanese ICUs from December 2012 to March 2014. Patients over 18 years of age undergoing CVC and AC placement in the ICU are randomized to have one of three skin antiseptic preparations before catheter insertion. After removal of the catheter, the distal tip is cultured using semiquantitative or quantitative techniques. The incidence of catheter colonization and catheter-related bloodstream infection (CRBSI) is compared between the three groups.</p></sec><sec sec-type="results"><title>Results</title><p>A total of 997 catheters were placed, including 339 catheters using 1% CHG, 329 using 0.5% CHG, and 329 using 10% PVI. The median duration of catheter indwelling in the entire population was3.7 days with an interquartile range of 2.0 to 6.7 days, with no significant difference between the groups (<italic>P </italic>= 0.36). Thirteen catheters (5.1%) in the 10% PVI group were positive for catheter-tip colonization, whereas six catheters (2.2%) in the 1% CHG group and five catheters (1.9%) in the 0.5% CHG group were positive (<italic>P </italic>= 0.07). The probability of catheter colonization was significantly higher in the 10% PVI group than each CHG groups (<italic>P </italic>= 0.028, log-rank test). The incidence of catheter colonization and CRBSI is compared between the three groups.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>In this randomized controlled trial comparing the effectiveness of three cutaneous antiseptic solutions for the prevention of catheter colonization, either 0.5% or 1.0% CHG was superior to 10% PVI.</p></sec></body></article>